Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Simcere Pharmaceutical Group Shares Popped: What You Need to Know

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Chinese drug company Simcere Pharmaceutical Group (NYSE: SCR  ) jumped 13% today after the company announced a fine at a company where it has controlling interest.

So what: Normally, a fine would be thought of as bad news, but this time investors are just happy to have the issue resolved. Jiangsu Yanshen, where Simcere holds a controlling 52.5% stake, will be fined 4.6 million renminbi for selling inferior products in addition to the 25.6 million renminbi it was fined by the Changzhou food and drug administration in May.

Now what: The fines have already been recorded in financial statements, so investors had priced in worse news, which is causing the pop today. From a performance standpoint, it is still not known when operations may continue at the plant in question. I would be leery of buying a stock with this kind of track record, but hopefully management has learned its lesson after facing individual punishments (details of the individual punishments weren't disclosed).

Interested in more info on Simcere Pharma? Add it to your watchlist.

Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings, or follow his Motley Fool CAPS picks at TMFFlushDraw.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 30, 2010, at 6:59 PM, jlanganki wrote:

    You didn't seem to do much research. The plant in question had the quality control problems before Simcere bought a controlling stake. You can't blame the new owners for something the prior owner did.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1384557, ~/Articles/ArticleHandler.aspx, 10/24/2016 10:22:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,240.01 94.30 0.52%
S&P 500 2,151.56 10.40 0.49%
NASD 5,302.73 45.33 0.86%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
SCR.DL $0.00 Down +0.00 +0.00%
Simcere Pharmaceut… CAPS Rating: No stars